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ABSTRACT
Mammalian transcriptome analysis has uncovered
tens of thousands of novel transcripts of unknown
function (TUFs). Classical and recent examples
suggest that the majority of TUFs may underlie
vital intracellular functions as non-coding RNAs
because of their low coding potentials. However,
only a portion of TUFs have been studied to date,
and the functional significance of TUFs remains
mostly uncharacterized. To increase the repertoire
of functional TUFs, we screened for TUFs whose
expression is controlled during differentiation of
pluripotent human mesenchymal stem cells
(hMSCs). The resulting six TUFs, named transcripts
related to hMSC differentiation (TMDs), displayed
distinct transcriptional kinetics during hMSC
adipogenesis and/or osteogenesis. Structural and
comparative genomic characterization suggested
a wide variety of biologically active structures of
these TMDs, including a long nuclear non-coding
RNA, a microRNA host gene and a novel small pro-
tein gene. Moreover, the transcriptional response to
established pathway activators indicated that most
of these TMDs were transcriptionally regulated by
each of the two key pathways for hMSC differentia-
tion: the Wnt and protein kinase A (PKA) signaling
pathways. The present study suggests that not only
TMDs but also other human TUFs may in general
participate in vital cellular functions with different
molecular mechanisms.
INTRODUCTION
Deep sequencing and high-density tiling microarray
studies of mammalian cDNAs recently revealed tens of
thousands of novel transcripts (1–3). These transcripts
diﬀer in size, splicing mode, polyadenylation status and
intracellular location. Because their functional roles are
currently unclear, they are designated as transcripts of
unknown function (TUFs) (4,5). In the post-genomic
era, the functional signiﬁcance of TUFs has received con-
siderable attention. Do most TUFs play important roles in
cellular mechanisms, or are they simply transcriptional
noise and functionally irrelevant (6,7)? As the majority
of human TUFs lack identiﬁable orthologs in other mam-
malian model organisms including mouse, answering
these questions may improve our understanding of
human-speciﬁc biology (8).
A common feature of TUFs is the low coding potential.
In sharp contrast with mRNAs, which generally contain a
single large open reading frame (ORF), TUFs have many
start and stop codons scattered throughout their entire
nucleotide sequences. Thus, TUFs always have several
small ORFs, and yet they rarely resemble any protein
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that most TUFs are non-coding RNAs (ncRNAs).
ncRNAs do have a variety of cellular roles (9,10).
Certain ncRNAs elicit gene regulatory functions by
producing small RNAs such as microRNAs and small
nucleolar RNAs (snoRNAs) (11). For more than a
decade, long and polyadenylated ncRNA genes such as
XIST [X (inactive)-speciﬁc transcript] have been known
to be functionally essential to gene regulation at a chro-
mosomal and global scale (12). Recently, the number of
functional ncRNAs has been expanded using diﬀerent
experimental approaches (13). For example, the identiﬁca-
tion of binding protein partners for TUFs is a straightfor-
ward strategy for understanding the molecular functions
of TUFs, as was done for HSR1 (heat shock RNA-1) (14).
Loss-of-function screening with short hairpin RNA
libraries against conserved mammalian TUFs led to the
discovery of NRON (non-coding repressor of transcrip-
tion factor NFAT) (15). These studies indicate that there
are far more TUFs for which the biological signiﬁcance
remains unknown.
In this study, we sought to identify human TUFs that
are involved in intracellular signaling pathways. The
intracellular signaling network sustains a variety of cell
functions including homeostasis, tumorigenesis and diﬀer-
entiation, and to our current knowledge, is governed
mostly by proteins. But one would expect that TUFs
could play vital roles in the signaling network, potentially
as ncRNAs, although no systematic eﬀort has been made
to seek such ‘signaling’ TUFs. Thus, this study attempted
to identify human TUFs that are regulated by any of the
major signaling pathways during human stem cell diﬀer-
entiation. In general, stem cells are transcriptionally
hyperactive as compared with diﬀerentiated cells (16),
and the induction of diﬀerentiation initiates global
and stepwise activation and/or inactivation of many
genes and signaling pathways (17,18). Human bone
marrow-derived mesenchymal stem cells (hMSCs) are
capable of ex vivo multi-lineage diﬀerentiation into
adipocytes, osteocytes, chondrocytes and even cells of
non-mesodermal origin, when treated with diﬀerentia-
tion-inducing reagents (19,20). By taking advantage of
this controllable cell diﬀerentiation system, we designed
a microarray speciﬁc for human TUFs to screen for
TUFs that exhibited changes of 5-fold or more in abun-
dance in the early stage of hMSC adipogenic or osteogenic
diﬀerentiation. These transcripts are referred to as tran-
scripts related to hMSC diﬀerentiation (TMDs). Sequence
analysis of the TMDs and their genomic loci allowed us to
categorize and determine the biologically active structures.
In order to identify the upstream-signaling pathways
for TMDs, we compared TMD transcription levels in
the presence and absence of established activators of the
Wnt or protein kinase A (PKA) signaling cascades, which
are known to govern hMSC diﬀerentiation (21–24). The
present study demonstrates that TMDs may play vital
roles in stem cell functions and moreover suggests that
other human TUFs have the potential to contribute to
many diﬀerent cellular phenomena with versatile
mechanisms.
MATERIALS AND METHODS
Cells, ex vivo differentiation and chemical induction of
signaling pathways
hMSCs (CD105-, CD166-, CD29- and CD44-positive;
<5% positive for CD14, CD34 and CD45) were pur-
chased from Cambrex (PT-2501, East Rutherford, NJ,
USA). In this study, hMSCs from two diﬀerent donors
were used for kinetic proﬁling of the TMDs and their
neighboring protein genes, as shown in Figures 1A, 2A,
3A, 4A and S2: #4F1560 (donor 1; female, 23-year-old,
African American) and #4F1301 (donor 2; male, 26-year-
old, Caucasian). For the subsequent and detailed charac-
terization of TMDs, only the hMSCs from donor 1 were
used. hMSCs were maintained in MSC basal medium
(MSCGM BulletKit, Lonza). hMSCs were expanded to
passage 4 before diﬀerentiation induction. For adipogenic
induction, sub-conﬂuent or conﬂuent cultures of cells
were treated and maintained in adipogenic induction
medium (hMSC Diﬀerentiation BulletKit, Adipogenic,
Lonza). For osteogenic induction, hMSC cultures that
were  10% conﬂuent were treated and maintained in
osteogenic induction medium (hMSC Diﬀerentiation
BulletKit, Osteogenic, Lonza). Cell stimulation by
dexamethasone (Dex), insulin, indomethacin, or isobutyl-
methylxanthine (IBMX) was performed at the concentra-
tion used in adipogenic induction medium. For the Wnt
activation experiment, Wnt3A (150ng/ml; R&D Systems)
was added to adipogenic induction medium. For PKA
activation experiments, forskolin (50mM; Calbiochem)
was added to MSC basal medium.
RNA extraction
Total RNA was extracted from hMSCs using the RNeasy
kit (Qiagen) and was treated with RNase-free DNaseI
(Qiagen) during extraction. For AGU1-speciﬁc cDNA
preparation (Figure 1E), polyA+ RNA was isolated
from total RNA using an Oligotex-dT30 <Super>
mRNA Puriﬁcation Kit (Takara). MicroRNAs as shown
in Figure 2C were isolated from total RNA using a
mirVana miRNA Isolation Kit (Ambion).
Microarray
A custom microarray for human TUFs was designed by
OligoArray 2.1 and obtained from Agilent Technologies.
The array included 14915 and 15092 probes for the sense
and antisense of 5489 non-protein-coding transcripts in
H-invitational Database (ver 2.0), respectively and 282
probes for 182 Erdmann ncRNAs. This array detects
expression at two or three diﬀerent locations on each
strand of the targeted TUFs. Total RNA from hMSCs
that were maintained in MSC basal medium or cultured
in diﬀerentiation-inducing medium conditions for 1, 3, or
7 days before RNA extraction was labeled with Cy3.
Samples were hybridized to the customized microarray
according to the manufacturer’s protocol. Arrays were
scanned with a G2565BA Microarray Scanner System
(Agilent Technologies). Data were analyzed using
GeneSpring GX software (Agilent Technologies).
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Total RNAs were reverse-transcribed using a QuantiTect
reverse transcription kit (Qiagen). The obtained cDNA
was ampliﬁed using ExTaq HS DNA polymerase
(Takara) and PCR primers listed in Supplementary
Table S1, and the resultant PCR products were analyzed
by 1% agarose gel electrophoresis as shown in Supplemen-
tary Figure S1.
Real-time RT–PCR
cDNA was prepared with the QuantiTect reverse tran-
scription kit (Qiagen) or the PrimeScript kit (Takara).
In both cases, random and oligo(dT) primers were used
except as follows. For AGU1-speciﬁc cDNA preparation
(Figures 1A, 1F, 5, 6 and S2A), total RNAs were reverse-
transcribed with AGU1-speciﬁc primers (AGU1_RT 1)
as well as 18S ribosomal RNA-speciﬁc (Figures 1A, 5, 6
and S2A) or Luc RNA-speciﬁc (Figure 1F) primers
as a normalization control, using the PrimeScript kit
(Takara). For AGU1-speciﬁc cDNA preparation
(Figure 1E), polyA+ RNAs were reverse-transcribed
with an AGU1-speciﬁc RT primer (AGU1_RT 2) as well
as a GAPDH-speciﬁc primer (GAPDH exon reverse) as a
normalization control. Real-time PCR analysis was per-
formed with a LightCycler 480 (Roche) or a Thermal
Cycler Dice Real Time System (Takara), using SYBR
Premix EX Taq (Takara) as the reaction reagent.
Results were analyzed based on the second derivative
method, and the resultant cycle threshold (Ct) values for
transcripts of interest were normalized to those for 18S
ribosomal RNA, GAPDH mRNA, or Luc RNA only as
shown in Figure 1F (see below for details). Two diﬀerent
sets of primers were used for the individual TMDs to
conﬁrm reproducibility of the transcription kinetics
(Figures S2 and S3). The primer sequences are listed in
Table S1.
To conﬁrm target speciﬁcities of the primer sets, real-
time PCR products after the 40 cycle reactions were gel
puriﬁed, cloned into pCRII-TOPO (Invitrogen), and
sequenced with the ABI PRISM BigDye Terminator
Cycle Sequencing kit (Applied Biosystems) using an ABI
3100 DNA sequencer (data not shown).
The intracellular abundance of three diﬀerently mature
microRNAs, hsa-mir-125b, hsa-let-7a and hsa-mir-100,
was measured using a TaqMan MicroRNA Assay
(Applied Biosystems) and normalized to RNU48.
5’ and 3’RACE
To determine the sequence of the 30-end of the AGU1
transcript, total RNAs from undiﬀerentiated hMSCs
or hMSCs cultured in adipogenic induction medium for
24h were reverse-transcribed with the 30RACE_RT
primer using a Superscript III ﬁrst-strand cDNA synthesis
kit (Invitrogen). The cDNAs obtained were ampliﬁed
with the AGU1_30RACE and 30RACE PCR primers. To
determine the sequence of the 50-end of the AGD1 tran-
script, total RNAs from undiﬀerentiated hMSCs were
reverse-transcribed using the FirstChoice RLM-RACE
kit (Ambion). The cDNAs obtained were ampliﬁed
with the AGD1_50RACE and 50RACE outer primers
(Ambion).
The resulting PCR products were analyzed on a 1%
agarose gel, puriﬁed using a gel extraction kit (Qiagen)
and cloned into pCRII-TOPO (Invitrogen). The inserts
were sequenced with the ABI PRISM BigDye Termina-
tor Cycle Sequencing kit (Applied Biosystems) using an
ABI 3100 DNA sequencer. These sequences were regis-
tered in GenBank (AB485960-AB485964 for AGD1
50RACE sequences, AB485715 for AGU1 30RACE
sequence).
Fractionation of total RNA from adipogenic hMSCs
hMSCs in a T25 ﬂask ( 10
6 cells) at 24h after adipogenic
induction as described above were trypsinized, washed
twice with ice-cold PBS, resuspended in lysis buﬀer
[10mM Tris–HCl (pH 8.0), 150mM NaCl, 0.5% NP-40,
1mM DTT, 1  Complete Protease Inhibitor Cocktail
(Roche), 100 U/ml RNAsin (Promega)] and centrifuged
at 1000 g for 3min at 48C. The supernatant was saved.
For preparation of the total cell fraction, hMSCs in a
T25 ﬂask ( 10
6cells) at 24h after adipogenic induction
were trypsinized, washed twice with ice-cold PBS and
resuspended in lysis buﬀer.
For normalization of RNA loss during RNA extrac-
tion, both cytoplasmic and total cell fractions were
spiked with an equal amount ( 1ng) of Renilla reniformis
luciferase RNA (Luc RNA). Luc RNA was synthesized
by in vitro transcription from pRL-CMV (Promega) with
T7 RNA Polymerase (TOYOBO) and puriﬁed with the
RNeasy kit (Qiagen) as speciﬁed by the manufacturers.
After total RNA extraction from both supernatant and
total cell fractions using an RNeasy kit (Qiagen) and
RNase-free DNaseI (Qiagen), real-time RT–PCR was per-
formed as described above to obtain Ct values for AGU1,
four diﬀerent control RNAs (mRNAs for ACTB,
GAPDH, GAPDH intron and U6 snRNA) and Luc
RNA in the cytoplasmic and total cell fractions. Ct
values for AGU1 and the control RNAs were normalized
to those for Luc RNA. The resultant Ct values (Ct0)
were used to calculate the fractions in the pellet using
the formula 1  ð 1=2½Ct0ðsupernatantÞ Ct0ðtotalÞ Þ:
Prediction of RNA secondary structure
Secondary structures of the highly conserved regions
within the AGU1 transcripts were predicted using the
RNA Mfold program (version 3.2) (25), using default
parameters. In all cases, the folding structures with the
lowest free energy are shown.
Preparation of polyclonal antibody against AGD3 protein
Three diﬀerent synthetic peptides derived from the N and
C terminus and the middle region of the AGD3 protein
(CGNSTATSAGAGQGP, CVNMVSSQTKTVRKN
and CTEDDKRRNYGGVYV, respectively) were conju-
gated with Inject Maleimide Activated mcKLH (Pierce)
and mixed with Freund’s Complete Adjuvant (Thermo
Scientiﬁc). Rabbits were immunized with a cocktail
of these three peptides and maintained for 8 weeks.
Antisera generated were puriﬁed by aﬃnity
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Activated Thiol Sepharose 4B (Pharmacia).
Immunoblotting
Undiﬀerentiated hMSCs and hMSCs cultured in adipo-
genic induction medium for 7 days were washed with 1 
PBS, lysed in lysis buﬀer [50mM Tris–HCl, (pH 8.0),
120mM NaCl, 1mM EDTA, 0.5% NP40, 1mM PMSF,
1  complete protease inhibitor cocktail (Roche)] and cen-
trifuged at 14000rpm for 15min. Protein concentration
was determined by DC protein assay (Bio-Rad). Each
protein sample (90mg) was analyzed by 15% SDS–
PAGE and electroblotted onto Immobilon-P membrane
(Millipore). The ﬁlters were blocked with 0.3% (w/v)
skim milk in 1  PBS/0.1% Tween 20 for 1h at room
temperature and then incubated with the anti-hAGD3
rabbit polyclonal antibody (1:100) or a mouse anti-
TUBA monoclonal antibody (1:500; sc-8035,
SantaCruz). Finally, the blots were incubated with perox-
idase-labeled donkey anti-rabbit IgG (1:5000; NA934V,
Amersham) or sheep anti-mouse IgG (1:2000; NA931V,
Amersham). Immunoreactive proteins were detected with
Immobilon Western Chemiluminescence HRP substrate
(Millipore) and the LAS-3000 system (Fuji Film).
RESULTS
Stem cell-based screening for functional human
TUF candidates
hMSCs from two diﬀerent donors were expanded in
growth medium until the fourth passage and then were
diﬀerentiated into one of the two lineages using estab-
lished protocols. Adipogenesis was induced by supplemen-
tation with four diﬀerent reagents (Dex, insulin,
indomethacin and IBMX), whereas osteogenesis was
initiated by a diﬀerent set of reagents (Dex, ascorbic
acid 2-phosphate and b-glycerophosphate). As hMSCs
were maintained in each of the diﬀerentiation media, the
diﬀerentiation marker genes for the individual lineages
were transcriptionally induced: ADIPOQ (adiponectin,
C1Q and collagen domain containing) for adipogenesis
and ALPL (alkaline phosphatase liver/bone/kidney) for
osteogenesis (Supplementary Figure S1).
To monitor TUF expression, we developed a DNA
microarray in which the probes target 182 Erdmann
ncRNAs (26) and 5489 transcripts annotated as non-pro-
tein-coding transcripts in the full-length human cDNA H-
invitational (H-inv) Database (ver. 2.0) (27). This micro-
array included two or three diﬀerent probes for each
strand of the targeted loci. Because the H-inv transcripts
possess only small ORFs (<240bp, corresponding to <80
amino acids), and the longest ORF for each transcript
encodes no functional protein sequence or motif, this
microarray was customized speciﬁcally for TUFs that
could be novel genes for ncRNAs or small proteins.
In addition, these transcripts varied in length, splicing
mode, polyadenylation status and retroelement content
so that our screen was unbiased within the context of
TUF primary sequences.
The initial screening by the customized microarray
allowed us to obtain TUFs for which the expression
levels increased or decreased by at least 5-fold on Day 1,
3 or 7 after hMSC adipogenic or osteogenic induction. To
add to the stringency of this screen, we selected only TUFs
for which all the probes on either strand indicated similar
changes in expression. We next performed manual inspec-
tion of mRNAs and ESTs assigned within and around the
transcribed regions of the obtained TUFs in the UCSC
Human Genome Browser (28) so as to exclude non-
full-length transcripts from the resultant TUFs.
Although the majority of the cDNA collections in the
H-inv Database are full-length transcripts cloned mostly
by oligo-capping (29), the collection probably includes
truncated transcripts from neighboring genes. Indeed,
many genomic regions producing TUFs overlapped anno-
tated genes, and some of these TUFs could represent trun-
cated forms of these overlapping gene transcripts that
were incorrectly annotated as independent full-length
transcripts. To exclude such experimental artifacts and
to acquire only the genuine independent full-length
TUFs for further characterization, the TUFs obtained
by the microarray screening were examined using the
following procedures. First, the relative transcriptional
orientations of the individual TUFs and their adjacent
or overlapping NCBI Reference Sequence (RefSeq)
genes were evaluated by conﬁrming the position of the
canonical polyadenylation (polyA) signal (AATAAA or
ATTAAA) and/or polyA tails at the 30-termini of the
mRNAs and ESTs assigned to the corresponding loci.
Anti-parallel orientation was regarded as evidence that
the TUF transcription units were independent from the
neighboring genes. When the transcriptional orientation
was parallel to adjacent RefSeq genes, nucleotide dis-
tances were also considered. In this study, TUFs that
were  5kb away from the nearest annotated gene were
labeled as independent transcripts. When TUFs over-
lapped with any RefSeq genes in the same orientation,
exon–intron structures were assessed to certify TUF
transcriptional independence: when a TUF was wholly
included within an intron of a RefSeq gene or vice
versa, both were considered independent transcriptional
units, even if they were transcribed on the same strand.
After this intensive manual evaluation of the genomic and
transcript structures, the TUFs that were likely to have
originated from independent transcription units were
ﬁnally subjected to quantitative RT–PCR to conﬁrm the
expression changes observed on the microarray.
This manual evaluation process identiﬁed six functional
TUF candidates, which are referred to as TMDs. TMDs
exhibited distinct expression kinetics within the two diﬀer-
ent lineages (see below). Five TMD loci were either up- or
downregulated more drastically during adipogenesis than
during osteogenesis, and thus these were named adipogen-
esis upregulating transcripts 1 and 2 (AGU1 and AGU2)
and adipogenesis downregulating transcripts 1, 2 and 3
(AGD1, AGD2 and AGD3), respectively. The last TMD
locus was upregulated only during osteogenesis and
was thus named osteogenesis upregulating transcript
1( OGU1).
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Because the representative EST for AGU1 (AK092105) is
located on the antisense strand of intron 9 of PAPPA
(pregnancy-associated plasma protein A), the expression
proﬁles during adipogenesis and osteogenesis were mea-
sured using cDNAs prepared with strand-speciﬁc
AGU1_RT 1 primer (Figure 1B). Transcription of the
EST locus was dramatically increased during adipogenesis,
morethanduringosteogenesis (Figure1A).Antisensetran-
scripts are often involved in cis-repression of transcription
of their sense counterparts, which usually results in a neg-
ative correlation between the two transcriptional states
(30). Unexpectedly, however, this was not the case for
AGU1. PAPPA mRNA levels changed by <5-fold
throughout the ﬁrst 7 days in each of the two lineages
(Supplementary Figure S2A). The discordant transcrip-
tional responses of AGU1 and PAPPA imply that, unlike
many examples of sense-antisense gene pairs, AGU1 may
not be a gene silencer of PAPPA, at least not during
hMSC adipogenesis. More importantly, the AGU1 locus
responded to adipogenesis induction by increasing tran-
scription independently of PAPPA, indicating that
AGU1 has distinct cis-regulatory elements controlled by
upstream signaling pathway(s) during adipogenesis.
The boundary of the AGU1 transcription unit was not
clear. Unlike the other TMDs, there was no EST cluster in
the AK092105 region in the UCSC Human Genome
Browser (31). To approximate both boundaries of the
AGU1 transcribed region, we took advantage of the
dramatic induction of AGU1 transcription during hMSC
adipogenesis. Expression changes at eight diﬀerent loca-
tions upstream or downstream of the AGU1 EST
(AK092105) were measured 24h after adipogenic induc-
tion (Figure 1B and C). As noted above, the AK092105
region [location (h)] displayed  50-fold induction;
furthermore, the transcriptionally activated region
spanned location (c) shown in Figure 1B. On the contrary,
the upstream position [Figure 1B, location (i)] exhibited
only a minor transcriptional response. Two diﬀerent sets
of PCR primers for diﬀerent exonic portions of PAPPA
mRNA (exons 2 4 and exons 9 10) showed only modest
expression changes, conﬁrming that transcription of the
PAPPA strand was largely unchanged. These results indi-
cate that AGU1 transcription starts around the original
EST region and ends between location (b) and (c) shown
in Figure 1B.
To identify the exact 30 terminus of the AGU1 tran-
scription unit, 30RACE was performed using an
AGU1_30RACE primer, which was targeted just down-
stream of location (c) (Figure 1B). Only the cDNA pre-
pared from hMSCs after adipogenic induction produced
a  1.0kb PCR product as a discrete band in an agarose
gel (Figure 1D). Cloning and sequencing conﬁrmed that
this PCR product had indeed originated from the 30 ter-
minus of the AGU1 transcript because it included the
polyA signal hexamer AATAAA close to the 30-terminal
polyA tail (Supplementary Figure S4). We then examined
whether this entire AGU1 region produced one consecu-
tive transcript. Northern blotting is commonly used to
estimate transcript length. We were, however, unable to
detect AGU1 transcripts, which was probably due to the
low cognate expression of AGU1, similar to many other
ncRNAs (data not shown). Therefore, we applied real-
time RT–PCR for this purpose. The AGU1-speciﬁc reverse
transcription primer AGU1_RT 2, which was designed to
hybridize to the upstream region of the AGU1 30 terminus
that we determined, was used to synthesize AGU1 cDNA
with polyA+ RNAs from undiﬀerentiated and adipogenic
hMSCs. Both cDNAs were then used for real-time PCR
with seven primer sets for locations (c) to (i). All the
expected locations except (c) and (i) showed signiﬁcant
increases in transcription levels after adipogenic induction
(Figure 1E). Similar to what is shown in Figure 1C,
location (i) showed no change, conﬁrming that the
AGU1 transcription start site is located between locations
(h) and (i). The absence of a transcriptional eﬀect at (c)
might be explained by the existence of any spliced intron
including location (c). In sum, the AGU1 locus spans the
antisense strand of introns 8 and 9 of PAPPA and quickly
responds to hMSC adipogenesis by producing at least one
 20kb polyA+ transcript.
Many kinds of regulatory RNAs are compartmenta-
lized in a particular intracellular location, and many
known ncRNAs reside in the nucleus and function as
gene regulators (10). To learn more about the molecular
characteristics of the AGU1 transcript, we fractionated
total RNAs from hMSCs cultured in adipogenesis induc-
tion medium for 24h into detergent-soluble supernatant
and detergent-insoluble pellet. We then examined the
distribution of AGU1 RNA using real-time RT–PCR
(Figure 1F). Whereas nuclear RNAs, U6 spliceosomal
snRNA and GAPDH (glyceraldehyde-3-phosphate dehy-
drogenase) intronic RNA, were predominantly found in
the pellet fraction, cytoplasmic control RNAs, ACTB (b-
actin) mRNA and GAPDH mRNA were located in the
supernatant fraction. With this nuclear/cytoplasmic frac-
tionation method, AGU1 RNA was found almost exclu-
sively in the pellet fraction, which suggests that the AGU1
transcript may be localized to the nucleus. Although the
overall sequence conservation of the AGU1 locus is fairly
low, this locus includes partial regions that are highly con-
served among mammals. Indeed, two of the conserved
regions [i.e. regions (I) and (II) shown in Figure 1B]
could code for RNA transcripts with relatively stable
secondary structures (Supplementary Figure S5). AGU1
RNA may interact with other nuclear molecules, through
these conserved structures, to fulﬁll its important role as a
ncRNA in hMSC adipogenesis.
AGD1: a host gene of clustered microRNAs
Despite slightly diﬀerent fold changes in the transcription
levels between hMSCs from diﬀerent donors, AGD1 tran-
scription was reduced more strongly during adipogenesis
than osteogenesis (Figure 2A). As shown in Figure 2B, the
AGD1 locus includes a known protein-encoding gene
BLID (BH3-like motif containing, cell death inducer),
as well as three microRNA loci (mir-125b, let-7a and
mir-100) within the AGD1 introns. All ﬁve transcribed
regions are on the same strand. BLID possesses its own
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Figure 1. Structural characterization of the AGU1 locus and transcripts. (A) Expression change in AGU1 during the ﬁrst 7 days of adipogenesis or
osteogenesis from two diﬀerent hMSC donors. The RNA levels were measured with real-time RT–PCR and normalized to 18S rRNA. Error bars
show the standard deviations. (B) Schematic drawing showing two transcription units in the AGU1 locus, an AGU1 representative EST (AK092105)
and PAPPA (pregnancy-associated plasma protein A) in the format of the UCSC Human Genome Browser. The transcriptional directions
are denoted by dotted arrows. Solid arrows, which are out of scale, indicate the locations and orientations of primers used for reverse transcription,
real-time PCR and 30RACE. At the bottom, the level of sequence conservation among the mammalian species (Mammal Cons) is indicated (31). Two
highly conserved regions (I and II) were predicted to fold into stable secondary structures (see Supplementary Figure S5). (C) Changes in transcrip-
tional levels at nine diﬀerent locations (a–i), shown in (B), and at two diﬀerent locations on PAPPA mRNA (exons 2 4 and exons 9 10) were
measured using real-time RT–PCR 24h after hMSC adipogenic induction. cDNA was prepared by reverse transcription of total RNA with both
random and oligo(dT) primers. Data were normalized to 18S rRNA abundance. Error bars show standard deviations. ND, not detected. (D) Agarose
gel electrophoresis of 30RACE products of AGU1 and ACTB (b-actin). The  1.0kb band appeared only on Day 1 after adipogenic induction, and
was conﬁrmed to be derived from the AGU1 locus by sequencing (see Supplementary Figure S4). (E) AGU1-speciﬁc real-time RT–PCR.
Transcriptional changes at seven diﬀerent locations (c–i) 24h after hMSC adipogenic induction were measured with cDNA prepared by reverse
transcription of polyA+ RNA and AGU1_RT 2 primer. Data were normalized to GAPDH mRNA expression. Error bars show standard deviations.
ND, not detected. (F) Cell fractionation analysis of AGU1 RNA. As controls, spliceosomal U6 snRNA and GAPDH intronic RNA were found in
the pellet, whereas mRNAs of ACTB and GAPDH were in the supernatant. Error bars show standard deviations.
4992 Nucleic Acids Research, 2009, Vol. 37,No. 15transcriptional promoter and terminator regions, but
these mature microRNAs could be generated by proces-
sing of spliced AGD1 intron RNAs. This idea is supported
by the 50RACE experiments, which showed that AGD1
cDNAs started at diﬀerent sites in undiﬀerentiated
hMSCs and that longer cDNAs covered all three
microRNA loci in their introns (Figure 2B). We next per-
formed TaqMan real-time RT–PCR and quantiﬁed
expression changes in the three individual mature
microRNAs during hMSC adipogenesis (Figure 2C). Of
the three microRNAs, only mir-100 showed a signiﬁcant
decrease in intracellular abundance, which was  2-fold at
7 days after adipogenesis induction. While AGD1 is the
unique locus for mir-100 in the human genome, there are
two paralogous loci for each of the other two microRNAs.
Therefore, assuming that the paralogous loci of let-7a and
mir-125b are expressed at higher levels than AGD1,w e
could explain the uneven fold changes in expression
levels of clustered microRNAs. Accordingly, expression
reduction at the AGD1 locus may contribute to hMSC
adipogenesis by balancing intracellular levels of its intro-
nic microRNAs with other microRNA loci.
AGD3: a novel small protein-encoding gene
AGD3 displayed a drastic reduction in expression by
 50-fold at Day 7 after adipogenic induction
(Figure 3A). The AGD3 transcript is the only TMD that
was previously investigated: it was reported to be an
ncRNA that is overexpressed in cancer tissues (overex-
pressed in colon carcinoma-1; OCC-1), although its
molecular function is still unknown (32). To assess the
functions of the AGD3 transcript, we investigated the
degree of sequence conservation across the entire AGD3
locus. The consecutive exons 3, 4 and 5 of an AGD3-repre-
sentative EST were highly conserved among mammals
(Figure 3B). Sequence analysis revealed that this region
of the EST does not possess any stop codons and thus
that the conserved region spanning from exons 1 to 5
constitutes a small 63-amino-acid ORF. Surprisingly, the
amino-acid sequences were highly conserved that were
deduced from orthologous genomic loci of other verte-
brates (Figure 3C). Human AGD3 protein shows 86%
and 68% sequence identity with the mouse and zebraﬁsh
orthologs, respectively. To examine whether this protein
was indeed expressed, we prepared a polyclonal antibody
against a peptide epitope derived from the putative
C-terminal region of human AGD3 protein. Western
blotting conﬁrmed that AGD3 expression is reduced
during hMSC adipogenesis at the protein level as well
(Figure 3D). This  10-kDa band was not detected in
cell lysates from hMSCs that were treated with anti-
AGD3 siRNAs (data not shown), demonstrating the
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Figure 2. Structural characterization of a microRNA host gene, AGD1.( A) Changes in expression of an AGD1 representative EST (AK091713)
during the ﬁrst 7 days of adipogenesis or osteogenesis in hMSCs from two diﬀerent donors. RNA levels were measured by real-time RT–PCR and
normalized to 18S rRNA. Error bars show standard deviations. (B) Genomic context of the AGD1 locus. A modiﬁed image from the UCSC Human
Genome Browser showing an AGD1 representative EST (AK091713), BLID (BH3-like motif containing, cell death inducer), three intronic
microRNAs (mir-125b, let-7a and mir-100) and the ﬁve diﬀerent 50RACE clones obtained in this study. The solid arrow and arrowheads, which
are both out of scale, denote the position and orientation of the AGD1-speciﬁc PCR primer for 50RACE (AGD1_50RACE) and microRNAs,
respectively. Dotted arrows indicate orientations of the transcripts. (C) TaqMan real-time RT–PCR measurement of the mature microRNAs
before and after 7 days of adipogenic induction. Error bars show standard deviations.
Nucleic Acids Research, 2009,Vol.37, No. 15 4993speciﬁcity of our antibody. Therefore, it is highly possible
that AGD3 RNA plays a vital role, not as a ncRNA but as
an mRNA for stem cell function and/or adipogenesis, and
that this role is maintained across vertebrates.
AGU2, AGD2 and OGU1: ncRNA candidates with differ-
ent structural aspects
The other three TMDs also exhibited >5-fold changes in
expression during hMSC adipogenesis or osteogenesis
(Figure 4A). Individual TMD expression was controlled
separately from the expression of neighboring genes, sug-
gesting a function for the observed changes in TMD tran-
scription during hMSC diﬀerentiation (Supplementary
Figure S2). AGU2 includes one H/ACA box snoRNA,
SNORA26, in one of the two introns (Figure 4B). This
small RNA, however, showed little change in its intracel-
lular abundance during hMSC adipogenesis by northern
blotting (data not shown). AGU2 contains another con-
served GC-rich region in the ﬁrst intron, which may be
processed as a not-yet-annotated small functional RNA.
This notion does, however, require more intensive analysis
of the function of AGU2.
From an evolutionary perspective, it is of interest that
transcription units of AGU2 as well as AGD2 are shaped
by retrotransposons. AGU2 contains a long terminal
repeat (LTR)-like element, which provides its polyA
signal. Similarly, for AGD2, an ancient class of long
interspersed nuclear element, LINE2 (L2), serves as a
transcription terminator and two other repeats, LINE1
(L1) and mammalian-wide interspersed repeat (MIR),
were integrated as splice donor sites (Figure 4C). These
examples demonstrate the involvement of retrotranspo-
son-derived sequences in TUF evolution and imply func-
tional linkages of the genomic repeats with ncRNAs.
On the contrary, the entire OGU1 locus including the pro-
moter region is highly conserved among mammals and
does not contain any retrotransposon-derived elements
(Figure 4D). Unlike AGD3, no conserved ORFs were
seen in the transcribed region of OGU1, which may func-
tion as a ncRNA.
Chemical stimuli for TMD expression alteration
During the process of in vitro adipogenesis used in this
study, the four diﬀerent reagents (Dex, insulin,
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Figure 3. Structural characterization of a novel small protein gene, AGD3.( A) Real-time RT–PCR measurement of AGD3 transcription level during
the ﬁrst 7 days of adipogenesis or osteogenesis in hMSCs from two diﬀerent donors. RNA levels were normalized to 18S rRNA. Error bars show
standard deviations. (B) Schematic drawing showing mammalian conservation of the nucleotide sequence in the AGD3 locus from the UCSC Human
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4994 Nucleic Acids Research, 2009, Vol. 37,No. 15indomethacin and IBMX) individually and cooperatively
induce activation and/or inactivation of multiple signaling
pathways. We speculated that TMD expression could be
functionally controlled by any of these signaling pathways
during adipogenesis. We thus determined which adipogen-
esis-inducing reagent(s) were responsible for the observed
expression changes of the individual AGUs and AGDs.
hMSCs were incubated for 24h in the presence of each or
all of the adipogenesis-inducing reagents, and the TMD
transcriptional levels under these ﬁve diﬀerent conditions
were quantiﬁed relative to those in the undiﬀerentiated
state.
Interestingly, the TMDs showed various responses
to the individual reagents (Figure 5). AGU1 was mostly
Dex responsive, similar to the adipogenesis marker gene
PPARG2 (peroxisome proliferator-activated receptor
gamma 2) (19,33,34), which also showed residual but
detectable transcriptional induction with Dex alone. Like
other adipogenesis master genes such as CEBPA (CCAAT
/enhancer binding protein, alpha) (35,36), AGU2
responded weakly to Dex and IBMX and showed higher
and signiﬁcant expression with all four reagents. This
implies that the AGU2 induction seen in adipogenesis
might be due to cooperative stimulation by these two che-
micals. For all three adipogenesis downregulating tran-
scripts, Dex induced  2-fold reductions, insulin and
indomethacin produced little change and the combination
of all four reagents induced a signiﬁcant reduction in
transcription. In contrast, IBMX induced the opposite
changes: stimulation of AGD1 and repression of AGD2
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Nucleic Acids Research, 2009,Vol.37, No. 15 4995and AGD3. Overall, these TMDs exhibited diﬀerent pat-
terns of transcriptional responses to the individual
reagents, suggesting that the transcription of each TMD
is controlled by a distinct set of upstream signaling
cascades.
Upstream signaling pathways of TMDs
Based on the chemical requirements for the individual
TMD responses, we attempted to determine the speciﬁc
pathways that regulate each of the TMDs. Of the adipo-
genesis-inducing reagents, Dex is a glucocorticoid hor-
mone and is involved in various signaling pathways
including the Wnt pathway (37,38). We tested whether
activation of the Wnt pathway moderated expression of
TMDs, especially Dex-responsive AGU1, during hMSC
adipogenesis (Figure 6A). Wnt activation by Wnt3A was
veriﬁed by suppressed expression of PPARG2 and
CEBPA, which are downstream transcription factors in
the Wnt pathway (39–41). As expected, Wnt3A signiﬁ-
cantly reduced Dex-responsive AGU1 levels, suggesting
that AGU1 is a Wnt target gene. Transcriptional levels
of the other TMDs were less aﬀected by Wnt3A or Dex
alone (Figures 5 and 6A), suggesting the involvement of
other pathways in their expression regulation.
IBMX inhibits phosphodiesterase, prevents cAMP
degradation and leads to activation of the PKA pathway
(24). We thus next investigated the eﬀect of the PKA path-
way on IBMX-responsive TMD expression by examining
the eﬀects of another PKA-activating chemical, forskolin.
Forskolin mostly mediated TMD expression responses
that were observed with IBMX (Figure 6B). In particular,
AGU2 and AGD1 were induced in a similar manner to
a known PKA downstream gene, PTGS2 (prostaglandin-
endoperoxide synthase 2) (42), whereas AGD3 was
signiﬁcantly suppressed. On the contrary, AGD2 demon-
strated a striking reduction in abundance only with
IBMX, which suggests that this TMD might be
regulated by IBMX-sensitive and forskolin-insensitive
signaling pathways. Overall, it appears that the PKA
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Figure 5. Eﬀects of the individual adipogenesis-inducing reagents upon
TMD expression changes during adipogenesis. Relative expression
changes of adipogenesis-related TMDs and two master transcription
factors (PPARG2 and CEBPA) after 24h treatment with none, each,
or all of the four adipogenesis-inducing reagents (dexamethasone, Dex;
insulin, Ins; indomethacin, Ind; isobutylmethylxanthine, IBMX) were
quantiﬁed by real-time RT–PCR. For the TMDs and CEBPA, expres-
sion levels induced by any of the reagents are indicated relative to those
in hMSCs that were treated with none of the adipogenesis-inducing
reagents (None). Because PPARG2 showed a detectable expression
level only with Dex and all four reagents, the former expression level
(Dex) is indicated relative to the latter one (All), which is normalized
to 100. ND, not detected. See Table S1 for primer sequences. Error
bars show standard deviations.
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Figure 6. Dissection of upstream-signaling pathways regulating TMD
transcription. (A) TMD expression changes by Wnt activation.
Expression levels of all the adipogenesis-related TMDs and Wnt
target genes (PPARG2 and CEBPA) were measured using real-time
RT–PCR 24h after adipogenic induction in the absence or presence
of Wnt3A (150ng/ml). The log ratio of the individual TMD expression
with versus without Wnt3A is shown on the y-axis. (B) TMD expres-
sion changes by PKA activation. Expression levels of all the adipogen-
esis-related TMDs and a PKA target gene (PTGS2) were measured
using real-time RT–PCR after 7-day treatment of hMSCs with forsko-
lin (50mM) or vehicle control (dimethyl sulfoxide). The ratio of the
individual TMD expression with versus without forskolin is shown
on the y-axis. See Table S1 for primer sequences. Error bars show
standard deviations.
4996 Nucleic Acids Research, 2009, Vol. 37,No. 15pathway is one of the upstream regulators of these
three TMDs.
DISCUSSION
Six diﬀerent transcripts that responded to hMSC diﬀeren-
tiation by undergoing dramatic changes in intracellular
abundance were newly identiﬁed from our unbiased
search for functional TUFs. Our homemade microarray
contained probes that target TUF collections that have a
wide variety of sequence characteristics such as the degree
of sequence conservation and repeat content. Genomic
screens for functional elements typically involve removing
repeated elements from the initial collections using
RepeatMasker (43). However, the intergenic regions of
the human genome, where TUFs are found, contain
many retrotransposon-derived repeats, with close to
50% of the genome containing such repeats (44).
Also, there is accumulating evidence showing that many
retrotransposon-derived elements are used as promoters,
enhancers, splice sites and polyA signals for known pro-
tein genes, as was seen for AGU2 and AGD2 (Figure 4)
(45,46). Knowing these impacts of repeats on gene evolu-
tion and regulation, the observed transcriptional
responses of these two TUFs during hMSC diﬀerentiation
indicate their functional importance. It is also possible
that repeats embedded chimerically in TUFs could be
involved in TUF function.
Although the extent of sequence conservation across
species of the entire TUF nucleotide sequence seems
low, TUFs possess partially conserved regions, enabling
us to identify structures of potentially functional entities in
TMDs. One of the most striking and unexpected ﬁndings
in this study is that AGD3 encodes a novel protein that is
conserved from humans to zebraﬁsh (Figure 3C). It was
previously reported that this transcript was incapable of
translating protein from any of its possible ORFs in vitro
(32). Our results clearly show, however, that a protein
product is derived from the AGD3 transcript in hMSCs.
Previously, some ncRNAs have turned out to be mRNAs
for small regulatory proteins during fruit ﬂy development
(47,48). In mammals, the bioinformatic survey of the
FANTOM collection of mouse cDNAs estimated the
presence of at least 1200 new genes coding for small pro-
teins with <100 amino acids, most of which seemed to be
translated from putative ncRNAs (49). However, to our
knowledge, no studies have conﬁrmed the expression of
endogenous protein products from mammalian TUFs.
Thus, AGD3 is the ﬁrst human TUF that has been demon-
strated to encode a novel protein.
The high degree of conservation of the AGD3 amino
acid sequence across species strongly supports an evolu-
tionarily conserved role for this protein (Figure 3). In
addition, AGD3 was suppressed by the PKA pathway
during adipogenesis (Figure 6B). PKA signaling is one
of the key pathways in determining the commitment
of hMSCs to diﬀerentiate into either an adipogenic or
osteogenic lineage. The activation of PKA facilitates adi-
pogenesis (23,24). Moreover, the PKA pathway is critical
to cell growth and is likely involved in tumorigenesis (50).
In agreement with this idea, the AGD3 transcript was ini-
tially observed to be highly expressed in colon tumors,
indicating its involvement in cell proliferation and/or
the cell cycle (32). Future studies will be needed to
reveal mechanistic features of the AGD3 protein in
hMSC biology via the PKA pathway.
AGD1 is a polycistronic microRNA host gene, which
encodes mir-125b-1 (ﬂy lin-4), let-7a-2 and mir-100 in
its introns. Only mir-100 was downregulated concomi-
tantly with AGD1 reduction after hMSC adipogenesis
(Figure 2C). Any mechanistic links between mir-100 and
hMSC adipogenesis, however, remain speculative because
of a lack of functional information about mir-100 itself,
although the entire microRNA cluster seems linked
with hMSC-related biology. The intracellular abundance
of these three mature microRNAs was positively corre-
lated with neural diﬀerentiation; these microRNAs are
expressed predominantly in brain and are upregulated
during murine and human neural diﬀerentiation by reti-
noic acid (51,52). Although the results were not deﬁnitive,
hMSCs seem capable of neural diﬀerentiation (53,54).
Furthermore, the master transcriptional factor for adipo-
genesis, PPARG, also controls neural stem cell prolifera-
tion and diﬀerentiation (55). Taken together, one can
hypothesize that AGD1 reduction may be involved in
the fate of hMSCs (adipogenesis, self-proliferation, or per-
haps neurogenesis) through mir-100 and/or the other
spliced exonic transcripts.
AGU1 is a genuine non-coding RNA gene suppressed
by Wnt signaling (Figure 6A). Wnt signaling is important
for embryonic development and stem cell fate decision
into various lineages (56–59), and the Wnt pathway sti-
mulates osteogenesis and inhibits adipogenesis (60–62).
Our observation that adipogenic induction robustly upre-
gulated AGU1 by more than 50-fold only during adipo-
genesis is consistent with the hypothesis that AGU1 is one
of the genes driving hMSC adipogenesis (Figure 1). AGU1
RNA was likely to be restricted to the nucleus and thus
may be untranslated and functional as an ncRNA
(Figure 1F) (10). Walking-primer RT–PCR with AGU1-
speciﬁc cDNA revealed that AGU1 spanned  20kb
(Figure 1E). The  20kb transcribed region was included
in the antisense portion of intron 9 of PAPPA, the tran-
scriptional level of which remained unchanged during
hMSC adipogenesis. Therefore, we do not consider
AGU1 to be an antisense regulator of PAPPA expression;
rather, the AGU1 transcript may be a signaling ncRNA
that receives signals from the Wnt pathway for inactiva-
tion from the cytoplasm, potentially through its conserved
secondary structure(s), and contributes to hMSC adipo-
genesis progression by increasing its own nuclear
abundance.
Before concluding that these TMDs were under the con-
trol of these pathways, we conﬁrmed the independence
of the TMDs from their neighboring genes in terms of
both genomic structures and transcriptional responses
(Supplementary Figure S2). The exon–intron structures
and strand orientations of both the TMDs and their
neighboring genes were examined to ensure that the
TMD loci were transcription units that are independent
from adjacent and/or overlapping genes. Transcriptional
Nucleic Acids Research, 2009,Vol.37, No. 15 4997independence tends to be ignored, but it is very important
in screening for functional TUFs. Transcription of more
than one gene located in the same chromosomal locus is
often concomitantly controlled, for example, by bidirec-
tional promoters or global chromatin modiﬁcations (63),
and yet all of these genes do not always contribute to
downstream signaling (64). In other words, transcripts
expressed simultaneously with neighboring genes could
be transcriptional noise and thus functionally irrelevant.
Therefore, we validated non-correlated proﬁles of tran-
scriptional kinetics between the individual TMDs and
the corresponding adjacent gene(s) to conﬁrm TMD inde-
pendence in transcriptional regulation. Screening for
TUFs for which the transcriptional levels are changed
by physiologically active reagents is a useful strategy to
identify functional TUF candidates and subsequently val-
idate transcriptional independence of TUFs (65,66).
John Mattick’s group used mouse embryonic stem
cells and identiﬁed 174 polyadenylated TUFs that are dif-
ferentially expressed by at least 2-fold during diﬀerentia-
tion to embryoid bodies (66). Although there is a
diﬀerence in the number of identiﬁed TUFs between the
previous report and ours (possibly because our threshold
of a 5-fold expression diﬀerence was more stringent), both
studies demonstrate the utility of stem cells for screening
and subsequent characterization of functional TUF can-
didates. Stem-cell diﬀerentiation involves not only funda-
mental but also lineage-speciﬁc cellular mechanisms.
hMSCs and other human stem cells, including embryonic
or induced pluripotent stem cells, are useful in screening
for human-speciﬁc TUFs (67–69).
In conclusion, we have identiﬁed novel transcripts
under the control of two diﬀerent pathways in the intra-
cellular-signaling network. In general, functional redun-
dancy, which often interferes with the elucidation of
gene functions, is due to the presence of parallel pathways
producing the observed phenotypes. Therefore, our iden-
tiﬁcation of signaling pathways involving these transcripts
will assist in the experimental design for their functional
characterization. Understanding the signaling networks
in which TUFs and TMDs participate will help uncover
their molecular function and may help integrate TUFs
into a new paradigm of gene function.
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